Request a demo
360° view Sample input On-board reagents Available assays Learn about the benefits of syndromic testing

QIAstat-Dx Cartridge

SWAB port

Unique swab direct with onboard elution

MAIN port

Any liquid sample type up to 1,5 mL

INNOVATIVE solution

All reagents on-board to provide comprehensive results
in about an hour

Discover the QIAstat-Dx Analyzer

The next generation of multiplex syndromic testing

Explore features
Swab port
Onboard sample prep
Dimension (WxHxD): 108 x 25 x 52mm
Traceability barcode
Main port
Onboard reagent storage
Reaction chambers
Visual confirmation of loaded sample
Sealed cartridge design

QIAstat-Dx Cartridge

A fully-contained test that can detect over 20 targets. Simply add the sample and let the QIAstat-Dx system do the rest.

Available assays:

QIAstat-Dx Respiratory SARS-CoV-2 Panel

This expanded version of our multiplex respiratory cartridge detects and differentiates 22 viral and bacterial respiratory targets, including SARS-CoV-2.

Download the flyer

The QIAstat-Dx Analyzer and the QIAstat-Dx Respiratory SARS-CoV-2 Panel are intended for in vitro diagnostic use.

QIAstat-Dx Respiratory SARS-CoV-2 Panel

QIAstat-Dx Gastrointestinal Panel 2

True Sample to Insight solution for patients with suspected gastrointestinal infections

  • Detects 23 viral, bacterial and parasitic targets in about an hour
  • Wet and dry reagents on-board
  • No precision pipetting required
  • Room temperature storage

Download the flyer

The QIAstat-Dx Analyzer and the QIAstat-Dx Gastrointestinal Panel 2 are intended for in vitro diagnostic use.

QIAstat-Dx Gastrointestinal Panel

QIAstat-Dx Meningitis/Encephalitis Panel

True Sample to Insight solution for patients with suspected meningitis and/or encephalitis

  • Detects 15 viral, bacterial and fungal targets in about an hour
  • Wet and dry reagents on-board
  • No precision pipetting required
  • Room temperature storage

Download the flyer

The QIAstat-Dx Meningitis/Encephalitis (ME) Panel is indicated as an aid in the diagnosis of specific agents that cause meningitis and/or encephalitis, and results must be used in conjunction with other clinical, epidemiological, and laboratory data. Results from the QIAstat-Dx ME Panel are not intended to be used as the sole basis for diagnosis, treatment, or other patient management decisions. Positive results do not rule out co-infection with organisms not included in the QIAstat-Dx ME Panel. The agent or agents detected may not be the definite cause of the disease. Negative results do not preclude central nervous system (CNS) infection. The QIAstat-Dx ME Panel is intended for in vitro diagnostic use by laboratory professionals only.

QIAstat-Dx Gastrointestinal Panel

See QIAstat-Dx in action